Showing results (911-920 of 1,038) with videos related to
Sort By:
Pageof 104
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridolManish A Shah, Jeremy Kortmansky, Monica Motwani, et al.Cancers|November 13, 2021
A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal MelanomaAlexander N Shoushtari, Shaheer Khan, Kimberly Komatsubara, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2005
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistryKi Young Chung, Jinru Shia, Nancy E Kemeny, et al.Molecular Therapy. Methods & Clinical Development|September 11, 2024
Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse modelMegan C Baird, Shibi B Likhite, Tatyana A Vetter, et al.Clinical and Translational Science|December 22, 2023
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With LeiomyosarcomaLan Gao, Diksha Kaushik, Brian A Van Tine, et al.Nature Genetics|March 18, 1999
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophyG Bonne, M R Di Barletta, S Varnous, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2024
Single-Cell Profiling of Sarcomas from Archival Tissue Reveals Programs Associated with Resistance to Immune Checkpoint BlockadeKaran Luthria, Parin Shah, Blake Caldwell, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2022
A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated LiposarcomaMatthew Ingham, Shing Lee, Brian A Van Tine, et al.Cancers|September 27, 2025
Correction: Shoushtari et al. A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers 2021, 13, 5504Alexander N Shoushtari, Shaheer Khan, Kimberly Komatsubara, et al.American Journal of Clinical Oncology|August 3, 2005
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancersGhassan K Abou-Alfa, Eric K Rowinsky, Yehuda Z Patt, et al.Pageof 104